COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

An encouraging update: Young adults with vaccine-related heart damage see all symptoms resolve

“Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable," researchers wrote.

Thumbnail

A healthy heart can lower the risk of severe COVID-19 symptoms, new research confirms

“Clinicians and policymakers should consider that strategies which improve cardiovascular health may also improve outcomes for people following COVID-19," one researcher said. 

Thumbnail

Athletes fully recover from COVID-19 with no long-term heart damage

“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained. 

How later COVID-19 surges impacted heart attack and stroke numbers

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

Cardiac arrest numbers highlight the pandemic’s long-term impact on patient care

Researchers will be tracking COVID-19's impact on healthcare for many years to come.

Thumbnail

CDC reviewing cases of heart damage in young adults after COVID-19 vaccination

The American Heart Association has emphasized that the benefits of being vaccinated still "enormously outweigh" the risks. 

It’s official: Heart Rhythm 2021 is happening with no capacity restrictions

The meeting is scheduled for July 28-31 in Boston. A fully virtual option will still be available to anyone interested. 

Dapagliflozin fails to reduce the risk of organ failure or death among COVID-19 patients

Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant. 

Displaying 193 - 200 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.